Fig. 1From: Treatment with G-CSF reduces acute myeloid leukemia blast viability in the presence of bone marrow stromaG-CSF treatment spares AML blasts while it increased surface CXCR4 expression. Primary patient AML cells were cultured in the presence of 0.1, 1 and 10 μg/mL of G-CSF for 24 and 72 h. a Cell viability was measured by live-death discrimination (7-AAD) and volumetric count by flow cytometry. b CXCR4 surface expression was measured by flow cytometry. ** p < 0.01; *** p < 0.005Back to article page